Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 10.98 USD 0.18% Market Closed
Market Cap: 419.7m USD

Intrinsic Value

The intrinsic value of one TRDA stock under the Base Case scenario is hidden USD. Compared to the current market price of 10.98 USD, Entrada Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

TRDA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Entrada Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

TRDA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether TRDA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about TRDA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TRDA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Entrada Therapeutics Inc.

Explain Valuation
Compare TRDA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TRDA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Entrada Therapeutics Inc

Current Assets 338.3m
Cash & Short-Term Investments 326.8m
Receivables 1.2m
Other Current Assets 10.2m
Non-Current Assets 74.6m
PP&E 70.5m
Other Non-Current Assets 4.1m
Current Liabilities 24m
Accounts Payable 3.2m
Accrued Liabilities 19.9m
Other Current Liabilities 971k
Non-Current Liabilities 48.2m
Other Non-Current Liabilities 48.2m
Efficiency

Free Cash Flow Analysis
Entrada Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Entrada Therapeutics Inc

Revenue
61.5m USD
Operating Expenses
-183.1m USD
Operating Income
-121.6m USD
Other Expenses
18.1m USD
Net Income
-103.5m USD
Fundamental Scores

TRDA Profitability Score
Profitability Due Diligence

Entrada Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
hidden
Profitability
Score

Entrada Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

TRDA Solvency Score
Solvency Due Diligence

Entrada Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Entrada Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRDA Price Targets Summary
Entrada Therapeutics Inc

Wall Street analysts forecast TRDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRDA is 16.83 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

Lowest
Price Target
13.13 USD
20% Upside
Average
Price Target
16.83 USD
53% Upside
Highest
Price Target
21 USD
91% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Entrada Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TRDA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TRDA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TRDA stock?

The intrinsic value of one TRDA stock under the Base Case scenario is hidden USD.

Is TRDA stock undervalued or overvalued?

Compared to the current market price of 10.98 USD, Entrada Therapeutics Inc is hidden .

Back to Top